Article Sidebar

Submitted
May 3, 2021
Published
May 3, 2021
Download
PDF
Statistic
Read Counter : 66 Download : 34

Main Article Content

Abstract

Background


Arthritis is one of the leading cause of disability in the world. A radiographic survey suggested that the prevalence of arthritis rises from 1% below 30 years and 50% in above 60 years. With this background the present study was conducted to evaluate the anti-rheumatoid arthritis effect of chrysie in freund’s induced arthritis in rats. 


Aim and Objective


To evaluate the anti-rheumatoid effect of Chrysin in freund’s induced arthritis in rats.


Materials and Methods


This study was conducted in the Department of Pharmacology, Rajah Muthiah Medical College, Annamalai University. It was done in the period of Jan 2012-Jan 2013 (1 year). 30 rats were divided in two five groups each group of 6 rats. G-I (Distilled water), G-II (Freund’s complete adjuvant), G-III (Dexamethasone 0.5 mg/kg), G-IV (Chrysin 50mg/kg) and G-V (Chrysin 100 mg/kg). All the animals were treated with their respective drugs for 56 days. –ray of rats joint was taken at 1st ,7th , 14th, 28th and 56th day. At the end of experiment rats were scarified and joint was separated and used for histopathology.


Results


G-II rats showed significant changes in joint X-ray and histopathology compared to control group. Co-administration of dexamethasone significantly prevented arthritic changes in joint compared to G-II. High dose chrysie showed effect similar to dexamethasone. 


Conclusion


Chrysin administration significantly prevented freund’s adjuvant induced arthritis in rats. It can be used in the treatment of rheumatoid arthritis and other inflammatory joint disorders. 

Keywords

Arthritis Inflammation Freund’s complete adjuvant Chrysin, X-ray Joint

Article Details

How to Cite
Vishnu R, & Krishnan R. (2021). Histopathological and x-ray based evaluation of anti-rheumatoid effect of chrysin in freund’s induced arthritis in wistar albino rats. International Journal of Research in Pharmacology & Pharmacotherapeutics, 6(4), 421-426. https://doi.org/10.61096/ijrpp.v6.iss4.2017.421-426
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. [1]. Arya RK, Jain V. Osteoarthritis of the Knee Joint - An Overview. Journal of Indian Academy of Clinical Medicine 14(2), 2013, 154-62.
  2. [2]. Parasannasrinivas D, Karthikeya P, Mahima V, Guledgud, Reema SD. Diagnostic imaging in TMJ osteoarthritis: A case report and overview. IJDSR 3(3), 2015, 56-9.
  3. [3]. Delisa AJ, Walter RF, Bruce MG, Nicolas EW, Lawrence RR. Rehabilitation of the patient with rheumatic diseases. Lippincott Williams & Wilkins, 40, 2010, 1015-21.
  4. [4]. Van derheide A, Jacobs JW. The effectiveness of early treatment with second line anti – rheumatic drugs . Annals of Internal Medicine 124, 1996, 699-707.
  5. [5]. Emery P, Foster W and Suarez M. Rheumatoid arthritis. Clinical Evidence 5, 2002, 1107-21.
  6. [6]. Kitas GD, Erb N, Tackling Ischemic Heart Disease in Rheumatoid Arthritis. Rheumatology 42, 2003, 607-13.
  7. [7]. Goronzy JJ, Weyand CM. Rheumatoid arthritis: Epidemiology, Pathology and pathogenesis. primer on the rheumatic diseases. Arthritis Foundation 2, 1997, 155-162.
  8. [8]. Panoulas VF, Metsios GS, Pace AV, John H. Hypertension in Rheumatoid Arthritis. Rheumatology 47, 2008, 1286-98.
  9. [9]. Genovese MC. Abatacept for Rheumatoid Arthritis Refractory to TNF-α inhibition. New England Journal of Medicine 353, 2005, 1114-6.
  10. [10]. Brandt Kenneth D, Dieppe P Radin Eric. Etiopathogenesis of osteoarthritis. Medical Clinics of North America 93(1), 2009, 1-24.
  11. [11]. Delisa AJ, Walter RF, Bruce MG, Nicolas EW, Lawrence RR. Rehabilitation of the patient with Rheumatic diseases. Lippincott Williams & Wilkins, 40, 2010, 1015-21.
  12. [12]. Ashman RB, Papadimitriou JM. Production and function of cytokines. IIR 18(1), 1995, 23-30.
  13. [13]. Ajay DK, Prashant VP, Uday NH, Rabindra KN, Haidarali MS. Anti-inflammatory and artharthritic activity of anthraquinone derivatives in rodents. IJI 2(1), 2014, 1-12.
  14. [14]. Snekhalatha U, Anburajan M, Venkatraman B, Menaka M. Evalaution of complete freund’s adjuvant induced arthritis in a Wistar rat model. Comparison of thermography and histopathology. J Rheumatol 72(4), 2013, 375-82.
  15. [15]. Boon YK, Siang Lc, Prabha B. Apoptotic effects of chrysin in Human Cancer Cell Lines. IJMS 11, 2010, 2188-99.
  16. [16]. Lukacinova A, Moizis J, Benacka R, Keller J, Maguth T, Kurila P. Preventive effects of flavonoids on Alloxan-induced Diabetes Mellitus in Rats . ACTAVET BRNO 77, 2008, 175 -182.
  17. [17]. Teng GG, Turkiewicz AM, Moreland LW: Abatacept : A costimulatory inhibitor for treatment of rheumatoid arthritis. Expert opinion inbiologicals therapy 5, 2005, 1245.
  18. [18]. Mamatha K, Rodda HC, Ciddi V, Bookya K. Anti-arthritic activity of root bark of Oroxylumindicum (L.) vent against adjuvant-induced arthritis. Pharmacognosy Res5(2), 2013, 121-.